Hershey says GLP-1s are driving higher gum and mint sales

Hershey said GLP-1 adoption is boosting demand for mints and gum, with Ice Breakers retail sales up over 8% in the quarter. Protein bar sales also jumped 17%, helping first-quarter revenue rise more than 10%. Shares were still down more than 2% in morning trading, suggesting the market is weighing the demand tailwind against broader concerns.

Analysis

The key takeaway is not that sweets are suddenly a GLP-1 beneficiary; it is that the category is fragmenting into “symptom-management” and “micro-indulgence” buckets. Mints, gum, and protein-forward snacks are gaining because they fit the behavioral loop of GLP-1 users: smaller, more functional, more frequent purchases. That creates a second-order distribution advantage for branded incumbents with shelf presence in convenience, pharmacy, and checkout, where small-basket replenishment can offset softness in legacy impulse candy over the next 2-4 quarters.

For HSY, the market is likely underappreciating the mix implication. The headline revenue pop is less important than whether these higher-frequency items can carry gross margin and advertising efficiency better than classic chocolate, which is more exposed to volatile cocoa and heavier promo intensity. If the GLP-1 adoption curve stays on track, the more durable upside is in adjacent wellness-snacking SKUs, not just confectionery, implying the real valuation re-rate should come from evidence that HSY can sustain share gains in protein and functional products into back-to-school and holiday resets.

The bearish setup is that this is still a narrow, early-cycle consumer behavior effect that can reverse quickly if GLP-1 utilization plateaus, insurers tighten coverage, or consumers adapt to side effects. That makes the trade more of a 3-6 month earnings/multiple story than a 2-3 year structural thesis. The consensus risk is overextrapolation: investors may assume all premium snacks benefit, when in reality the winners are likely the companies with the best pack architecture, route-to-market, and ability to capture small-basket repeat purchases rather than broad category beta.

Key Decisions for Investors

• Long HSY on pullbacks over the next 1-2 weeks; target a 6-10% move if the market starts pricing recurring functional-snack mix benefit, with a stop if the next print shows protein/mints decelerating sequentially.
• Pair long HSY / short a broad confection peer with less exposure to functional snacks and pharmacy-convenience channels for the next 1-2 quarters; the relative spread should widen if GLP-1-related demand proves sticky.
• Buy HSY call spreads 3-6 months out to express upside from a re-rating without paying full premium for a single-quarter beat; best risk/reward if implied volatility stays subdued after earnings.
• Trim exposure to pure-play impulse candy names if they lack protein or breath-freshening adjacency; the category is shifting toward utility-led purchase occasions, and those names may underperform over 2-3 quarters.
• Watch for retailer planogram resets and scanner data in convenience/pharmacy over the next 30-60 days; a continued lift there would confirm the trade, while normalization would be an exit signal.